ArticleJournal of biomedicine & biotechnology2011

Cervicovaginal safety of the formulated, biguanide-based human immunodeficiency virus type 1 (HIV-1) inhibitor NB325 in a murine model.

Karissa Lozenski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.